Stock listing
A2PSZF Stock Price, News, Filings & Events — Relmada Therapeutics, Inc.
Selected listing: A2PSZF · LS · EUR · DE
This page tracks Relmada Therapeutics, Inc.'s A2PSZF:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PSZF:LS. A2PSZF:LS is the stock-level entry point for investors researching Relmada Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2PSZF:LS
- Asset type
- Stock
- Market cap
- $461.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Relmada Therapeutics, Inc. A2PSZF:LS stock context
This page tracks Relmada Therapeutics, Inc.'s A2PSZF:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PSZF:LS. A2PSZF:LS is the stock-level entry point for investors researching Relmada Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Relmada Therapeutics, Inc.
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
July 28, 2026
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
July 16, 2026
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
June 29, 2026
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
June 11, 2026
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
May 28, 2026
Relmada Therapeutics, Inc. earnings calls
Relmada Therapeutics, Inc. (RLMD) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call
March 19, 2026 · Replay with transcript and chapters
Relmada Therapeutics, Inc. (RLMD) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Relmada Therapeutics, Inc. (RLMD) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Relmada Therapeutics, Inc. (RLMD) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Research Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2PSZF:LS.
Relmada Therapeutics, Inc. company profile
View the public company page for Relmada Therapeutics, Inc. on 6ix.
Relmada Therapeutics, Inc. news
Read company news and market updates connected to Relmada Therapeutics, Inc..
Relmada Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Relmada Therapeutics, Inc..
Alternate listings
RLMD:NASDAQ
US · USD
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:GETTEX
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
A2PSZF:LSX
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
RLMD:BOATS
US · USD
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:FWB
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:TRADEGATE
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:DUS
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:HAM
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:MUN
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.
4E2:SWB
DE · EUR
Alternate listing for Relmada Therapeutics, Inc.; the primary context on this page is A2PSZF:LS.